This study is an an observational prospective cohort research study to explore the performance of new blood and urine tests for the early detection of cancer among firefighters.
Study Type
OBSERVATIONAL
Enrollment
2,000
multi-cancer early detection (MCED) test
Vincere Cancer Center
Scottsdale, Arizona, United States
RECRUITINGSensitivity, specificity, positive and negative predictive performance values (PPV and NPV) to detect cancer using Elypta's MCED test, as measured in plasma, in urine, and in plasma and urine combined
Time frame: Up to 7 years
Sensitivity, specificity, positive and negative predictive performance values to detect cancer using Proteotype's MCED test, as measured in plasma.
Time frame: Up to 2030
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.